196 Airway infection and inflammation in people with cystic fibrosis treated with 1 year of elexacaftor-tezacaftor-ivacaftor—the RECOVER study

Autor: Nolan, S., Weldon, S., Lester, K., Elnazir, B., Williamson, M., Cox, D., Linnane, B., O’Regan, P., Kirwan, L., McKone, E., Reid, A., Davies, J., McNally, P., Downey, D., Taggart, C.
Zdroj: In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S102-S102
Databáze: ScienceDirect